Urinary Stents or Ureteral Stents Market Report 2025

This Urinary Stents or Ureteral Stents market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The urinary stents or ureteral stents market size has grown strongly in recent years. It will grow from $0.48 billion in 2024 to $0.51 billion in 2025 at a compound annual growth rate (CAGR) of 6.87%. The growth during the historical period can be credited to the increased prevalence of urological conditions, higher demand for advanced urinary stent solutions, greater adoption of minimally invasive procedures, a stronger focus on patient comfort and shorter recovery times, and advancements in stent material technologies.

The urinary stents or ureteral stents market size is expected to see strong growth in the next few years. It will grow to $0.66 billion in 2029 at a compound annual growth rate (CAGR) of 6.64%. In the forecast period, growth is expected to be driven by rising demand for personalized urinary stent solutions, heightened healthcare awareness among patients, a growing incidence of kidney stones, increased healthcare investments, and an expanding geriatric population. Key trends anticipated during this period include innovations in minimally invasive techniques, improvements in ureteral stent designs, the launch of new products, technological advancements, and the development of biodegradable hydrogel stents.

The growing prevalence of kidney diseases is anticipated to drive the expansion of the urinary or ureteral stents market. Conditions such as chronic kidney disease (CKD), kidney stones, urinary tract obstructions, and infections are increasingly affecting kidney function and structure worldwide. Factors such as rising rates of diabetes, hypertension, obesity, aging populations, poor lifestyle habits, environmental influences, and delayed diagnosis contribute to this increase. Urinary stents are crucial for managing these conditions by facilitating proper urine flow, preventing blockages, and supporting kidney function, particularly in cases involving chronic kidney disease, kidney stones, and urinary obstructions. For example, according to the Australian Institute of Health and Welfare, mortality rates from chronic kidney disease rose from 4.2% in 2021 to 6.2% in 2022. Consequently, the increasing prevalence of kidney diseases is fueling the growth of the urinary stents market.

Leading companies in the urinary stents market are prioritizing the development of innovative products designed to enhance patient comfort and minimize risks. Novel stents, characterized by unique features and improvements over existing designs, exemplify this focus. In May 2022, University Hospitals, in partnership with the Ureteral Stent Company, achieved FDA 510(k) clearance for the Relief Ureteral Stent. This advanced stent, made from cutting-edge materials and featuring a unique structure, reduces patient discomfort and lowers the risk of complications such as encrustation or migration. Its enhanced durability and flexibility improve long-term performance for patients with urinary tract obstructions. The FDA clearance underscores the stent’s safety and effectiveness, representing a significant advancement in urology.

In February 2023, Olympus Corporation acquired Taewoong Medical Co. Ltd. for approximately $370 million. This acquisition aims to strengthen Olympus’s gastrointestinal device portfolio and expand its expertise in minimally invasive treatments by integrating Taewoong Medical’s advanced stent technologies. Taewoong Medical, based in Korea, specializes in manufacturing gastrointestinal metallic stents and ureteral stents.

Major players in the urinary stents or ureteral stents market are Becton, Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Coloplast A/S, Teleflex Incorporated, Cook Medical LLC, Merit Medical Systems Inc., Lepu Medical Technology Co. Ltd., Olympus Corporation, Applied Medical Resources Corporation, Ameco Medical Equipment LLC, Well Lead Medical Co. Ltd., Micro-Tech Nanjing Co. Ltd., Medi-Globe GmbH, Pnn Medical A/S, Taewoong Medical Co. Ltd., Rocamed SAM, HydrUStent SA, Urovision GmbH, MED PRO MEDICAL B.V.

North America was the largest region in the urinary stents or ureteral stents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in urinary stents or ureteral stents report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the urinary stents or ureteral stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Urinary stents, also referred to as ureteral stents, are medical devices placed in the ureters (the tubes connecting the kidneys to the bladder) to maintain or restore the flow of urine. These stents are commonly used to address blockages, injuries, or narrowing in the ureters caused by conditions such as kidney stones, tumors, or post-surgical complications. They are essential in preventing urine backup, reducing the risk of kidney damage, and alleviating symptoms such as pain or infection.

The main types of urinary or ureteral stents include open-end stents, closed-end stents, double pigtail stents, and multiloop stents. Open-end stents are tubular devices designed to maintain open passages, ensuring unobstructed urine flow in cases of ureteral blockage. Materials used for manufacturing these stents include metallic stents, polymer stents, and biodegradable hydrogel stents. They are applied in treating kidney stones, kidney failure, urinary tract infections, urinary incontinence, and other conditions. The primary end users of these stents are hospitals and specialty centers, ambulatory surgical centers, and academic and research institutes.

The urinary stents or ureteral stents market research report is one of a series of new reports that provides urinary stents or ureteral stents market statistics, including the urinary stents or ureteral stents industry global market size, regional shares, competitors with the urinary stents or ureteral stents market share, detailed urinary stents or ureteral stents market segments, market trends, and opportunities, and any further data you may need to thrive in the urinary stents or ureteral stents industry. This urinary stents or ureteral stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The urinary stents or ureteral stents market consists of sales of double-J stents, non-coated stents, metallic stents, and percutaneous nephrostomy stents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.